Nothing Special   »   [go: up one dir, main page]

TR201011148A1 - Levetirasetam farmasötik bileşimleri. - Google Patents

Levetirasetam farmasötik bileşimleri.

Info

Publication number
TR201011148A1
TR201011148A1 TR2010/11148A TR201011148A TR201011148A1 TR 201011148 A1 TR201011148 A1 TR 201011148A1 TR 2010/11148 A TR2010/11148 A TR 2010/11148A TR 201011148 A TR201011148 A TR 201011148A TR 201011148 A1 TR201011148 A1 TR 201011148A1
Authority
TR
Turkey
Prior art keywords
pharmaceutical compositions
levetiracetam
levetiracetam pharmaceutical
relates
epilepsy
Prior art date
Application number
TR2010/11148A
Other languages
English (en)
Inventor
Çi̇fter Ümi̇t
Türkyilmaz Ali̇
Gürpinar Hakan
Erdem Yelda
Yildirim Edi̇z
Original Assignee
Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ filed Critical Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇
Priority to TR2010/11148A priority Critical patent/TR201011148A1/tr
Priority to PL11196040.7T priority patent/PL2471520T3/pl
Priority to ES11196040.7T priority patent/ES2582012T3/es
Priority to EP11196040.7A priority patent/EP2471520B1/en
Priority to PT111960407T priority patent/PT2471520T/pt
Publication of TR201011148A1 publication Critical patent/TR201011148A1/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Mevcut buluş levetirasetamm farmasotik tablet bileşimleriyle ilgilidir. Buluş aynca bileşimlenn üretimi için bir proses ve epilepsi tedavisinde kullanımıyla da ilgilidir.
TR2010/11148A 2010-12-30 2010-12-30 Levetirasetam farmasötik bileşimleri. TR201011148A1 (tr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
TR2010/11148A TR201011148A1 (tr) 2010-12-30 2010-12-30 Levetirasetam farmasötik bileşimleri.
PL11196040.7T PL2471520T3 (pl) 2010-12-30 2011-12-29 Kompozycja farmaceutyczna lewetyracetamu
ES11196040.7T ES2582012T3 (es) 2010-12-30 2011-12-29 Composiciones farmacéuticas de levetiracetam
EP11196040.7A EP2471520B1 (en) 2010-12-30 2011-12-29 Pharmaceutical compositions of levetiracetam
PT111960407T PT2471520T (pt) 2010-12-30 2011-12-29 Composições farmacêuticas de levetiracetam

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2010/11148A TR201011148A1 (tr) 2010-12-30 2010-12-30 Levetirasetam farmasötik bileşimleri.

Publications (1)

Publication Number Publication Date
TR201011148A1 true TR201011148A1 (tr) 2012-07-23

Family

ID=44487143

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2010/11148A TR201011148A1 (tr) 2010-12-30 2010-12-30 Levetirasetam farmasötik bileşimleri.

Country Status (5)

Country Link
EP (1) EP2471520B1 (tr)
ES (1) ES2582012T3 (tr)
PL (1) PL2471520T3 (tr)
PT (1) PT2471520T (tr)
TR (1) TR201011148A1 (tr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
CN111920778A (zh) * 2020-08-12 2020-11-13 湖北欣泽霏药业有限公司 一种左乙拉西坦片及其制备方法
CN117838643A (zh) * 2023-12-29 2024-04-09 山东力诺制药有限公司 一种吡拉西坦片及其制备方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060165796A1 (en) * 2005-01-27 2006-07-27 Alembic Limited Extended release formulation of levetiracetam
WO2006123357A2 (en) * 2005-02-22 2006-11-23 Sun Pharmaceutical Industries Limited Oral controlled release composition containing levetiracetam
WO2009135646A2 (en) * 2008-05-05 2009-11-12 Farmaprojects, Sa Stable pharmaceutical compositions and their processes for preparation suitable for industrial scale
EP2277511A1 (en) * 2009-07-22 2011-01-26 Sanovel Ilac Sanayi ve Ticaret A.S. Extended release pharmaceutical compositions of levetiracetam
WO2011019956A2 (en) * 2009-08-12 2011-02-17 Biovail Laboratories International (Barbados) S.R.L. Pharmaceutical compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2524771T3 (es) 2005-07-26 2014-12-12 Ucb Pharma, S.A. Composiciones farmacéuticas que comprenden levetiracetam y procedimientos para su preparación

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060165796A1 (en) * 2005-01-27 2006-07-27 Alembic Limited Extended release formulation of levetiracetam
WO2006123357A2 (en) * 2005-02-22 2006-11-23 Sun Pharmaceutical Industries Limited Oral controlled release composition containing levetiracetam
WO2009135646A2 (en) * 2008-05-05 2009-11-12 Farmaprojects, Sa Stable pharmaceutical compositions and their processes for preparation suitable for industrial scale
EP2277511A1 (en) * 2009-07-22 2011-01-26 Sanovel Ilac Sanayi ve Ticaret A.S. Extended release pharmaceutical compositions of levetiracetam
WO2011019956A2 (en) * 2009-08-12 2011-02-17 Biovail Laboratories International (Barbados) S.R.L. Pharmaceutical compositions

Also Published As

Publication number Publication date
ES2582012T3 (es) 2016-09-08
PT2471520T (pt) 2016-07-22
EP2471520B1 (en) 2016-04-20
PL2471520T3 (pl) 2016-12-30
EP2471520A1 (en) 2012-07-04

Similar Documents

Publication Publication Date Title
CY1123549T1 (el) Σταθερη φαρμακευτικη συνθεση και μεθοδοι χρησης αυτης
TN2015000278A1 (en) Autotaxin inhibitors
MA33803B1 (fr) Inhibiteur de bromodomaine de benzodiazépine
TR201902788T4 (tr) Nörodejeneratif hastalıkların tedavisinde kullanışlı 1-arilkarbonil-4-oksi-piperidin bileşikleri.
UA110612C2 (uk) Похідні 1-аміно-2-циклопропілетилборонової кислоти
TN2014000138A1 (en) Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases.
WO2012088266A3 (en) Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
IN2014MN00948A (tr)
IN2012MN02591A (tr)
GB201106750D0 (en) Novel compounds
MX344238B (es) Compuestos de tetrazol y métodos para preparar y usar los mismos.
MY163275A (en) Ibat inhibitors for the treatment of liver diseases
TW201711676A (en) Ferric citrate dosage forms
CY1120204T1 (el) Αμορφη στερεα διασπορα για χρηση σε θεραπεια καρκινου του εγκεφαλο
EA201171435A1 (ru) Твердые фармацевтические композиции и способы их получения
MX349224B (es) Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa.
BR112013010694A2 (pt) composições antitranspirantes ativas e sua produção
MY166449A (en) Pharmaceutical composition of rosuvastatin calcium
MX357284B (es) Compuestos de quinona para tratar enfermedades mediadas por ape1.
EA201270728A1 (ru) Пуриновые соединения
TR201009167A2 (tr) Sefalosporin içeren farmasötik granüller.
EA201171414A1 (ru) Ингибиторы белков семейства iap
IN2014DN03010A (tr)
TR201011148A1 (tr) Levetirasetam farmasötik bileşimleri.
MX2014004210A (es) Derivados de 2-oxo-piperidinilo.